Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
28.9M
-
Number of holders
-
147
-
Total 13F shares, excl. options
-
22.1M
-
Shares change
-
+258K
-
Total reported value, excl. options
-
$501M
-
Value change
-
+$5.65M
-
Put/Call ratio
-
0.01
-
Number of buys
-
78
-
Number of sells
-
-53
-
Price
-
$22.72
Significant Holders of CASTLE BIOSCIENCES INC - Common Stock (CSTL) as of Q1 2023
167 filings reported holding CSTL - CASTLE BIOSCIENCES INC - Common Stock as of Q1 2023.
CASTLE BIOSCIENCES INC - Common Stock (CSTL) has 147 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22.1M shares
of 28.9M outstanding shares and own 76.34% of the company stock.
Largest 10 shareholders include WASATCH ADVISORS LP (2.98M shares), BlackRock Inc. (2.12M shares), VANGUARD GROUP INC (1.4M shares), PRINCIPAL FINANCIAL GROUP INC (1.29M shares), Granahan Investment Management, LLC (1.2M shares), Bellevue Group AG (949K shares), MILLENNIUM MANAGEMENT LLC (825K shares), CITADEL ADVISORS LLC (661K shares), KORNITZER CAPITAL MANAGEMENT INC /KS (648K shares), and PALISADE CAPITAL MANAGEMENT, LP (577K shares).
This table shows the top 147 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.